购物车
全部删除
您的购物车当前为空
CK2-IN-15 (Compound Biv5) 是一种有效且具有选择性的二价蛋白激酶CK2抑制剂,IC50值为51 pM。它在HEK-ACE2-TMPRSS2和Vero细胞中显著降低了SARS-CoV-2的复制,在人类鼻上皮细胞的体外模型中也显示出抑制病毒复制的效果。CK2-IN-15 有潜力用于研究与 β 冠状病毒感染相关的疾病。
CK2-IN-15 (Compound Biv5) 是一种有效且具有选择性的二价蛋白激酶CK2抑制剂,IC50值为51 pM。它在HEK-ACE2-TMPRSS2和Vero细胞中显著降低了SARS-CoV-2的复制,在人类鼻上皮细胞的体外模型中也显示出抑制病毒复制的效果。CK2-IN-15 有潜力用于研究与 β 冠状病毒感染相关的疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
CK2-IN-15 相关产品
| 产品描述 | CK2-IN-15 (Compound Biv5) is a selective and potent inhibitor of the enzyme protein kinase CK2, with an IC50 value of 51 pM. It significantly reduces the replication of SARS-CoV-2 in HEK-ACE2-TMPRSS2 and Vero cells, and also decreases viral replication in an in vitro model of human nasal epithelial cells. CK2-IN-15 holds potential for research into diseases related to β-coronavirus infections. |
| 靶点活性 | CK2α:51 pM |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容